| # | Drug | Count |
|---|---|---|
| 0 | LEVETIRACETAM | 55 |
| 1 | LEVETIRACETAM IN SODIUM CHLORIDE | 49 |
| 2 | LEVETIRACETAM INJECTION | 49 |
| 3 | LEVETIRACETAM ORAL | 49 |
| 4 | LACOSAMIDE | 28 |
| 5 | ZONISAMIDE | 27 |
| 6 | CLONAZEPAM | 24 |
| 7 | CARBAMAZEPINE | 16 |
| 8 | EVEROLIMUS | 16 |
| 9 | TOPIRAMATE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZONISAMIDE | 27 | 0.0025 |
| 1 | VIGABATRIN | 11 | 0.0007 |
| 2 | LACOSAMIDE | 28 | 0.0007 |
| 3 | LEVETIRACETAM ORAL | 49 | 0.0006 |
| 4 | LEVETIRACETAM INJECTION | 49 | 0.0006 |
| 5 | OXCARBAZEPINE | 9 | 0.0006 |
| 6 | NITRIC OXIDE | 2 | 0.0004 |
| 7 | LEVETIRACETAM | 55 | 0.0004 |
| 8 | FENFLURAMINE | 2 | 0.0004 |
| 9 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-epileptic Agent [EPC] | 42 |
| 1 | Benzodiazepine [EPC] | 28 |
| 2 | Mood Stabilizer [EPC] | 20 |
| 3 | Kinase Inhibitor [EPC] | 18 |
| 4 | mTOR Inhibitor Immunosuppressant [EPC] | 17 |
| 5 | Corticosteroid [EPC] | 7 |
| 6 | Alkylating Drug [EPC] | 6 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 6 |
| 8 | Purine Antimetabolite [EPC] | 6 |
| 9 | Provitamin D2 Compound [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-epileptic Agent [EPC] | 42 | 0.0002 |
| 1 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 2 | 0.0002 |
| 2 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 3 | Mood Stabilizer [EPC] | 20 | 0.0001 |
| 4 | Barbiturate [EPC] | 1 | 0.0001 |
| 5 | Purine Antimetabolite [EPC] | 6 | 0.0001 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 7 | Benzodiazepine [EPC] | 28 | 0.0000 |
| 8 | Kinase Inhibitor [EPC] | 18 | 0.0000 |
| 9 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |